NCT05819346

Brief Summary

The aim of this study is to assess the efficacy of a digital lifestyle intervention in non-small cell lung cancer (NSCLC) survivors on health-related quality of life (HRQoL) over three months.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2023

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 6, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 19, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

August 1, 2023

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

January 30, 2025

Status Verified

January 1, 2025

Enrollment Period

2.3 years

First QC Date

April 6, 2023

Last Update Submit

January 28, 2025

Conditions

Keywords

Physical activityExerciseNutritionBreathingRelaxationMobile applicationRehabilitation aftercare

Outcome Measures

Primary Outcomes (1)

  • Health-related quality of life (Scale-Global health status)

    European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) (2 items; 7-point Likert-type scale; the score ranges from 0 to 100; a high score for the global health status represents a high HRQoL)

    Change from baseline to 3 months

Secondary Outcomes (11)

  • Health-related quality of life (5 functional scales, 9 symptom scales/items)

    Change from baseline to 3 months

  • Lung cancer-specific health-related quality of life (10 symptom scales/items)

    Change from baseline to 3 months

  • Body mass index [kg/m²]

    Change from baseline to 3 months

  • Physical activity (self-reported)

    Change from baseline to 3 months

  • Functional exercise capacity

    Change from baseline to 3 months

  • +6 more secondary outcomes

Other Outcomes (4)

  • Usability (intervention group only)

    At 3 months follow-up (end of the intervention)

  • Acceptability, appropriateness, and feasibility (intervention group only)

    At 3 months follow-up (end of the intervention)

  • Experiences and satisfaction with the digital lifestyle intervention (intervention group only)

    At 3 months follow-up (end of the intervention)

  • +1 more other outcomes

Study Arms (2)

Digital lifestyle intervention

EXPERIMENTAL

Self-management mobile application covering physical activity, nutrition, and breathing/relaxation

Behavioral: Lifestyle

Control

NO INTERVENTION

Usual care (study participation does not interfere with or change any other planned treatments)

Interventions

LifestyleBEHAVIORAL

Participants assigned to the intervention group receive access to a lifestyle mobile application for three months after rehabilitation or treatment has finished. The digital program is target group-specific and includes personalization and interactive elements without face-to-face appointments during the intervention. One virtual appointment at the beginning of the intervention with the study staff ensures that participants familiarize themselves with the mobile application and that they are assigned to a suitable program level. The intervention is mainly based on the following behavior change technique (BCT) clusters: goals and planning, feedback and monitoring, shaping knowledge, and comparison of behavior.

Digital lifestyle intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 18 years
  • Diagnosis of non-small cell lung cancer (NSCLC)
  • Estimated life expectancy of ≥ six months (judged by local investigators/responsible health professionals)
  • Undergoing inpatient or outpatient rehabilitation OR completion of planned surgery, chemotherapy, or radiation therapy for NSCLC within the past 24 weeks
  • Knowledge of German to understand study material and assessments
  • Access to a cell phone or tablet
  • Written informed consent

You may not qualify if:

  • Inability to provide informed consent
  • Inability to participate in the intervention because of physical, cognitive, or safety reasons (judged by local investigators/responsible health professionals)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Klinik Barmelweid AG

Barmelweid, 5017, Switzerland

RECRUITING

Zürcher RehaZentren | Klinik Davos

Davos, 7272, Switzerland

RECRUITING

Berner Reha Zentrum AG

Heiligenschwendi, 3625, Switzerland

RECRUITING

Zürcher RehaZentren | Klinik Wald

Wald, 8636, Switzerland

RECRUITING

Related Publications (1)

  • Weber M, Raab AM, Schmitt KU, Busching G, Marcin T, Spielmanns M, Puhan MA, Frei A. Efficacy of a digital lifestyle intervention on health-related QUAlity of life in non-small cell LUng CAncer survivors following inpatient rehabilitation: protocol of the QUALUCA Swiss multicentre randomised controlled trial. BMJ Open. 2024 Mar 7;14(3):e081397. doi: 10.1136/bmjopen-2023-081397.

    PMID: 38453202BACKGROUND

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell LungMotor ActivityRespiratory Aspiration

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesBehaviorRespiration DisordersPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Anja Frei, PhD

    University of Zurich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Sponsor

Study Record Dates

First Submitted

April 6, 2023

First Posted

April 19, 2023

Study Start

August 1, 2023

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

January 30, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will share

Pseudonymized data will be made available upon reasonable request after the main results have been published. The privacy of each subject and confidentiality of their information will be preserved in reports and publication of data.

Shared Documents
STUDY PROTOCOL, ICF

Locations